These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35410160)

  • 1. Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
    Mujuni D; Kasemire DL; Ibanda I; Kabugo J; Nsawotebba A; Phelan JE; Majwala RK; Tugumisirize D; Nyombi A; Orena B; Turyahabwe I; Byabajungu H; Nadunga D; Musisi K; Joloba ML; Ssengooba W
    BMC Infect Dis; 2022 Apr; 22(1):363. PubMed ID: 35410160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
    PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
    Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
    BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
    Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
    PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and profiles of drug resistance-conferring mutations in
    Reta MA; Maningi NE; Fourie PB
    Front Public Health; 2024; 12():1356826. PubMed ID: 38566794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    Ogari CO; Nyamache AK; Nonoh J; Amukoye E
    BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh.
    Mishra M; Pandey A; Chaturvedi P; Chaudhary E; Bisht AS
    Indian J Tuberc; 2024; 71 Suppl 1():S77-S80. PubMed ID: 39067960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line Drug Resistance Characterization in
    Sethi S; Agarwal P; Khaneja R; Kumar N; Kumar N; Chandna J; Aggarwal AN; Yadav R
    J Epidemiol Glob Health; 2020 Mar; 10(1):42-45. PubMed ID: 32175709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of Mycobacterium tuberculosis Complex Strains Isolated from the Samples of Patients Living in Northern Syria].
    Gazel D; Çeylan K; Çalışkantürk G; Karslıgil T
    Mikrobiyol Bul; 2023 Jul; 57(3):444-453. PubMed ID: 37462307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.
    Nehru VJ; Jose Vandakunnel M; Brammacharry U; Ramachandra V; Pradhabane G; Mani BR; Vn AD; Muthaiah M
    Sci Rep; 2024 Aug; 14(1):19719. PubMed ID: 39181942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
    Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
    Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
    Dixit R; Mohan E; Gupta A; Patni T
    Indian J Tuberc; 2024; 71 Suppl 1():S37-S43. PubMed ID: 39067953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Sci Rep; 2021 Apr; 11(1):7765. PubMed ID: 33833390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.
    Desikan P; Panwalkar N; Chaudhuri S; Khan Z; Punde RP; Pauranik A; Mirza SB; Ranjan R; Anand S; Sachdeva KS
    Trans R Soc Trop Med Hyg; 2020 Apr; 114(4):249-254. PubMed ID: 32003797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.